Abstract
Background At present, evidence is inconclusive regarding what factors influence vaccine intent, and whether there are widespread disparities across populations and time. The current study provides new insights regarding vaccine intent and potential differences across 23 countries and over time.
Methods Our data come from a unique longitudinal survey that contains responses from Facebook users (N=1,425,172) from the 23 countries from four continents collected in 18 waves from July 2020 through March 2021.
Results We find that vaccine intent varies significantly across countries and over time. Across countries, there are notable disparities in intent to vaccinate. Regarding time, intent has recently reached an all-time high. Our data demonstrates that intent to vaccinate has increased as countries have deployed vaccines on larger scales with undecidedness declining. However, there are some countries where vaccine intent is stagnant and in one country – Egypt – where it seems to have declined.
Interpretations Large numbers of citizens across the world are willing to get vaccinated. In the vast majority of countries in our sample, these were high enough to reach more conservative levels of herd immunity1 if combined with numbers of persons already infected. As such, the main barrier to vaccination is not vaccine hesitancy, but the shortage of vaccines. This sends a clear message to politicians who need to work on a quick and fair distribution of vaccine; and to scientists who need to focus their attention on understanding remaining pockets of vaccine skepticism or undecidedness and on factors that explain actual vaccine behavior, rather than intent.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
not applicable
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data used in the analysis come from the global survey of Facebook users on COVID-19 beliefs, behaviors, and norms collected by the Massachusetts Institute of Technology, and the survey questions were reviewed and approved by the Committee on the Use of Humans as Experimental Subjects at MIT. Data released to researchers do not include any identifiable information and hence we were exempt from completing the Human Subject Protection review at our institutions. For more information about the publicly available survey questions and ethics review process guiding the data collected by MIT, please see the preprint: https://psyarxiv.com/srv6t/
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
abkgpt{at}rit.edu
gerit.pfuhl{at}uit.no
d.schieferdecker{at}fu-berlin.de
caseyh{at}uark.edu
cdtidwel{at}uark.edu
kfitzpa{at}uark.edu
saggsh{at}rit.edu
sa9368{at}rit.edu
1 N total sample = 1,425,172; but not all provided age and gender, hence N demographics = 1,370,350)
Data Availability
Microdata is only available after signing DUA with MIT and Facebook, we therefore cannot provide those data. Aggregated data can be found at https://covidsurvey.mit.edu/
